Sodium-iodide symporter and its related solute carriers in thyroid cancer

Z Gong, M Wei, AC Vlantis, JYK Chan… - Journal of …, 2024 - joe.bioscientifica.com
The solute carrier (SLC) family is a large group of membrane transport proteins. Their
dysfunction plays an important role in the pathogenesis of thyroid cancer. The most well …

Functional characterization of novel compound heterozygous missense SLC5A5 gene variants causing congenital dyshormonogenic hypothyroidism

GH Carro, M Martín, S Savy, V Peyret… - Frontiers in …, 2024 - frontiersin.org
Introduction The sodium/iodide symporter (NIS) mediates active iodide accumulation in the
thyroid follicular cell. Biallelic loss-of-function variants in the NIS-coding SLC5A5 gene …

Novel molecular ty** reveals the risk of recurrence in patients with early-stage papillary thyroid cancer

M Sun, B Zhao, T Chen, L Yao, X Li, S Hu, C Chen… - Thyroid Research, 2024 - Springer
Background Papillary thyroid cancer (PTC) is an indolent disease with a favorable prognosis
but characterized by a high recurrence rate. We aimed to improve precise stratification of …

A New Twist on a Classic: Enhancing Radioiodine Uptake in Advanced Thyroid Cancer

MG Lechner, GA Brent - Clinical Cancer Research, 2024 - AACR
Advanced differentiated thyroid cancer that is resistant to radioactive iodine therapy may
become responsive with a unique treatment combination of chloroquine and vorinostat. This …